The Phase-2 CCR5-targeting Leronlimab With Oral Chemotherapy and VEGF-inhibitor Enriched Regimen Trial (CLOVER) (CLOVER)
Im not sure exactly what they are looking for.
Looks like one new trial site added
https://clinicaltrials.gov/study/NCT06699836?...y-overview